The feasibility of gene therapy in the treatment of head and neck cancer

被引:4
|
作者
Vattemi, Emanuela [2 ]
Claudio, Pier Paolo [1 ,3 ]
机构
[1] Marshall Univ, Joan C Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA
[2] Univ Verona, Sect Med Oncol, Dept Clin & Expt Med, I-37126 Verona, Italy
[3] Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV 25755 USA
关键词
SQUAMOUS-CELL CARCINOMA; PHASE-II TRIAL; RECURRENT HEAD; ATTENUATED ADENOVIRUS; TUMOR-SUPPRESSOR; P53; STATUS; ONYX-015; REPLICATION; E1A; EXPRESSION;
D O I
10.1186/1758-3284-1-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Standard approach to the treatment of head and neck cancer include surgery, chemotherapy, and radiation. More recently, dramatic increases in our knowledge of the molecular and genetic basis of cancer combined with advances in technology have resulted in novel molecular therapies for this disease. In particular, gene therapy, which involves the transfer of genetic material to cells to produce a therapeutic effect, has become a promising approach. Clinical trials concerning gene therapy strategies in head and neck cancer as well as combination of these strategies with chemotherapy and radiation therapy will be discussed.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Impact of Acid Ceramidase Expression on Head and Neck Cancer Proliferation, a Novel Target for Head and Neck Gene Therapy
    Liu, Xiang
    Marrison, Sarah Tucker
    Meacham, William D.
    McPherson, Alex
    Cheng, Joe
    Turner, Lorianne S.
    Day, Terry
    Hannun, Yusuf A.
    Norris, James S.
    MOLECULAR THERAPY, 2009, 17 : S104 - S104
  • [42] FasL gene therapy: a new therapeutic modality for head and neck cancer
    S ElOjeimy
    J C McKillop
    A M El-Zawahry
    D H Holman
    X Liu
    D A Schwartz
    T A Day
    J-Y Dong
    J S Norris
    Cancer Gene Therapy, 2006, 13 : 739 - 745
  • [43] DEVELOPING A NOVEL GENE-THERAPY FOR HEAD AND NECK-CANCER
    LIU, TJ
    TAYLOR, DL
    ZHANG, WW
    ROTH, JA
    GEOPFERT, H
    CLAYMAN, GL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 425 - 425
  • [44] FasL gene therapy: a new therapeutic modality for head and neck cancer
    ElOjeimy, S.
    McKillop, J. C.
    El-Zawahry, A. M.
    Holman, D. H.
    Liu, X.
    Schwartz, D. A.
    Day, T. A.
    Dong, J. -Y.
    Norris, J. S.
    CANCER GENE THERAPY, 2006, 13 (08) : 739 - 745
  • [45] Considerations of somatic gene therapy in head and neck squamous cell cancer
    Wollenberg, B
    Naujoks, K
    Kastenbauer, E
    LARYNGO-RHINO-OTOLOGIE, 1996, 75 (06) : 356 - 362
  • [46] Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Marianne Schmidt
    Tonja Heimberger
    Petra Gruensfelder
    Gabriele Schler
    Florian Hoppe
    European Archives of Oto-Rhino-Laryngology and Head & Neck, 2004, 261 : 208 - 215
  • [47] Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Schmidt, M
    Heimberger, T
    Gruensfelder, P
    Schler, G
    Hoppe, F
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2004, 261 (04) : 208 - 215
  • [48] Alloantigen gene therapy for head and neck cancer: Evaluation of animal models
    Gleich, LL
    Li, YQ
    Li, SN
    Gluckman, JL
    Stambrook, PJ
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (04): : 274 - 279
  • [49] Clinical photodynamic therapy: The evolution of photodynamic therapy treatment of head and neck cancer
    Biel, Merrill A.
    JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2024, 28 (06) : 338 - 348
  • [50] TREATMENT OF CANCER OF THE HEAD AND NECK
    SHAH, JP
    LYDIATT, W
    CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (06) : 352 - 368